ONCY Latest Headlines

Oncolytics Biotech Enters Clinical Supply Agreement with Coherus

at www.tipranks.com (Thu, 12-Nov 9:14 AM)

Patrick Trucchio Maintains Buy Rating and Unchanged $5 Price Target as Coherus Agreement Revives Pelareorep’s Development Path

at www.tipranks.com (Thu, 12-Nov 6:45 AM)

Pelareorep Data Show Enhanced Immune Activity in Multiple Myeloma

at www.tipranks.com (Mon, 9-Nov 10:08 AM)